Administration of non oral androgenic steroids to women
CA 2376797 C · Owner: Mazer, Norman A. · Inventors: Rosario-Jansen, Theresa; Mazer, Norman A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compositions methods, and kits for improving , health in a woman having elevated sex hormone binding globulin (SHBG) levels or who is receiving oral estrogen , supplementation by non-orally administering an , effective amount of an androgenic steroid. Further the present invention , provides compositions methods and kits for , coadminister-ing an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation. Fig. 1 shows the change in total testoterone level versus baseline SHBG level during application of transdermal testoterone patch (300 mcg/day …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 9, 2000 and granted March 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 9, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 9, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.